These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34030576)

  • 1. The role of inflammatory parameters in predicting disease recurrence in patients with stage IIA colon cancer with no high-risk features.
    Erdur E; Yildirim OA; Poyraz K; Aslan F; Yıldız F; Kömek H
    Postgrad Med; 2021 Aug; 133(6):694-700. PubMed ID: 34030576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative prognostic nutritional index predicts risk of recurrence after curative resection for stage IIA colon cancer.
    Maruyama T; Shimoda M; Hakoda H; Sako A; Ueda K; Suzuki S
    Am J Surg; 2021 Jul; 222(1):179-185. PubMed ID: 33138968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer.
    Zhang W; Liu K; Ye B; Liang W; Ren Y
    Cancer Med; 2018 Jan; 7(1):105-113. PubMed ID: 29193777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer.
    Dolan RD; McSorley ST; Horgan PG; McMillan DC
    Medicine (Baltimore); 2018 Mar; 97(13):e0185. PubMed ID: 29595652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
    Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
    Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
    Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer.
    Ding PR; An X; Zhang RX; Fang YJ; Li LR; Chen G; Wu XJ; Lu ZH; Lin JZ; Kong LH; Wan DS; Pan ZZ
    Int J Colorectal Dis; 2010 Dec; 25(12):1427-33. PubMed ID: 20821217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
    Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
    Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
    [No Abstract]   [Full Text] [Related]  

  • 12. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.
    Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M
    Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Inflammatory Biomarkers as Surrogate Markers for Stage in Colon Cancer.
    Uludag SS; Sanli AN; Zengin AK; Ozcelik MF
    Am Surg; 2022 Jun; 88(6):1256-1262. PubMed ID: 33596111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: A propensity score-matched analysis.
    Galizia G; Lieto E; Zamboli A; De Vita F; Castellano P; Romano C; Auricchio A; Cardella F; De Stefano L; Orditura M
    Surgery; 2015 Jul; 158(1):112-20. PubMed ID: 25818659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
    Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive values of the postoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio for the diagnosis of early periprosthetic joint infections: a preliminary study.
    Zhao G; Chen J; Wang J; Wang S; Xia J; Wei Y; Wu J; Huang G; Chen F; Shi J; Lyu J; Liu C; Huang X
    J Orthop Surg Res; 2020 Nov; 15(1):571. PubMed ID: 33256763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
    Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
    J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
    Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
    Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
    Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
    World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.